Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E M Lord

Showing results (71-80 of 108) with videos related to

Pageof 11
Sort By:
Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy|November 1, 1993
Interleukin-3 inhibits the generation of nonspecific killers by interleukin-2A J McAdam, K Y Yeh, B A Pulaski, et al.
Planta|January 1, 1996
Lily cofactor-independent phosphoglycerate mutase: purification, partial sequencing, and immunolocalizationJ L Wang, L L Walling, G Y Jauh, et al.
Cancer Research|May 1, 1993
Interleukin 3 enhances development of tumor-reactive cytotoxic cells by a CD4-dependent mechanismB A Pulaski, A J McAdam, E K Hutter, et al.
The Journal of Investigative Dermatology|December 24, 1997
Expression of B7-1 by Pam 212 squamous cell carcinoma enhances tumor cell interactions with dendritic epidermal cells but does not affect in vivo tumor growthK Y Yeh, Z Chen, A Nasir, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 24, 1998
IL-3 enhances both presentation of exogenous particulate antigen in association with class I major histocompatibility antigen and generation of primary tumor-specific cytolytic T lymphocytesK Y Yeh, A J McAdam, B A Pulaski, et al.
Neuroscience|June 11, 1999
Detection of hypoxic cells with the 2-nitroimidazole, EF5, correlates with early redox changes in rat brain after perinatal hypoxia-ischemiaM Bergeron, S M Evans, F R Sharp, et al.
British Journal of Cancer|October 1, 1995
Identification of hypoxia in cells and tissues of epigastric 9L rat glioma using EF5 [2-(2-nitro-1H-imidazol-1-yl)-N-(2,2,3,3,3-pentafluoropropyl) acetamide]S M Evans, B Joiner, W T Jenkins, et al.
International Journal of Cancer. Supplement = Journal International Du Cancer. Supplement|January 1, 1991
Class-I MHC expression in the mouse lung carcinoma, line 1: a model for class-I inducible tumorsT M Blieden, A J McAdam, M D Foresman, et al.
British Journal of Cancer|June 5, 2003
Mechanism of IL-12 mediated alterations in tumour blood vessel morphology: analysis using whole-tissue mountsS A Gerber, J P Moran, J G Frelinger, et al.
International Journal of Cancer|May 29, 1995
Synergistic effects of co-expression of the TH1 cytokines IL-2 and IFN-gamma on generation of murine tumor-reactive cytotoxic cellsA J McAdam, B A Pulaski, S S Harkins, et al.
Pageof 11

Showing results (71-80 of 108) with videos related to

Sort By:
Pageof 11
Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy|November 1, 1993
Interleukin-3 inhibits the generation of nonspecific killers by interleukin-2A J McAdam, K Y Yeh, B A Pulaski, et al.
Planta|January 1, 1996
Lily cofactor-independent phosphoglycerate mutase: purification, partial sequencing, and immunolocalizationJ L Wang, L L Walling, G Y Jauh, et al.
Cancer Research|May 1, 1993
Interleukin 3 enhances development of tumor-reactive cytotoxic cells by a CD4-dependent mechanismB A Pulaski, A J McAdam, E K Hutter, et al.
The Journal of Investigative Dermatology|December 24, 1997
Expression of B7-1 by Pam 212 squamous cell carcinoma enhances tumor cell interactions with dendritic epidermal cells but does not affect in vivo tumor growthK Y Yeh, Z Chen, A Nasir, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 24, 1998
IL-3 enhances both presentation of exogenous particulate antigen in association with class I major histocompatibility antigen and generation of primary tumor-specific cytolytic T lymphocytesK Y Yeh, A J McAdam, B A Pulaski, et al.
Neuroscience|June 11, 1999
Detection of hypoxic cells with the 2-nitroimidazole, EF5, correlates with early redox changes in rat brain after perinatal hypoxia-ischemiaM Bergeron, S M Evans, F R Sharp, et al.
British Journal of Cancer|October 1, 1995
Identification of hypoxia in cells and tissues of epigastric 9L rat glioma using EF5 [2-(2-nitro-1H-imidazol-1-yl)-N-(2,2,3,3,3-pentafluoropropyl) acetamide]S M Evans, B Joiner, W T Jenkins, et al.
International Journal of Cancer. Supplement = Journal International Du Cancer. Supplement|January 1, 1991
Class-I MHC expression in the mouse lung carcinoma, line 1: a model for class-I inducible tumorsT M Blieden, A J McAdam, M D Foresman, et al.
British Journal of Cancer|June 5, 2003
Mechanism of IL-12 mediated alterations in tumour blood vessel morphology: analysis using whole-tissue mountsS A Gerber, J P Moran, J G Frelinger, et al.
International Journal of Cancer|May 29, 1995
Synergistic effects of co-expression of the TH1 cytokines IL-2 and IFN-gamma on generation of murine tumor-reactive cytotoxic cellsA J McAdam, B A Pulaski, S S Harkins, et al.
Pageof 11